OrphanPulse Wk 42: Europe Backed Ascendis’ Weekly Achondroplasia Shot Ahead of the First Pill

FDA holds a public meeting at White Oak on 28 October, facilitated by the Reagan-Udall Foundation, and Medical Daily reports comments are open through 11 December. FDA says only about 5% of rare conditions have an approved treatment.